$5.890
-0.137 (-2.32%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SPRY Prediction & Forecast by Similar Chart Analysis
Alphio's SPRY stock price prediction model matches the current ARS Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.88 (-0.20%). The 1-week path is $5.99 (+1.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy ARS Pharmaceuticals Inc Stock?
ARS Pharmaceuticals Inc is currently trading at $5.89, significantly below analyst price targets of $25 and $30, indicating potential upside. However, the company has a troubling net income of -$62.34 million for Q2 2026 and faces class action lawsuits, which pose risks. The RSI is at 51.14, suggesting the stock is neither overbought nor oversold, but the recent 23% drop due to insurance coverage issues raises concerns about market confidence. Therefore, while there is potential for growth, the risks are substantial, warranting a hold position for now.
SPRY stock price ended at $5.89 on Friday, after losing -2.32%
ARS Pharmaceuticals Inc (SPRY) last closed at $5.89, losing -2.32%. These facts feed the 1-day and 1-week SPRY price prediction above.
Forecast Drivers
ARS Pharmaceuticals Inc (SPRY) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SPRY, ranked by similarity.
Seasonality analysis for SPRY
Historically the probability of a positive August return for SPRY is 68.25%. May offers the highest probability of a positive month at 68.25%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SPRY
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $29.36 | $32.52 | $49.58 | +452.05% |
| Sep 2026 | $31.79 | $32.52 | $32.87 | +452.05% |
| Oct 2026 | $44.41 | $48.27 | $49.95 | +719.50% |
| Nov 2026 | $21.36 | $33.41 | $45.12 | +467.20% |
| Dec 2026 | $33.53 | $48.27 | $57.15 | +719.50% |
In 2026, ARS Pharmaceuticals Inc (SPRY) is projected to range from $21.36 to $57.15.
ARS Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, ARS Pharmaceuticals Inc is projected to average $32.52, with a low of $29.36 and high of $49.58.
In Sep 2026, ARS Pharmaceuticals Inc is projected to average $32.52, with a low of $31.79 and high of $32.87.
In Oct 2026, ARS Pharmaceuticals Inc is projected to average $48.27, with a low of $44.41 and high of $49.95.
In Nov 2026, ARS Pharmaceuticals Inc is projected to average $33.41, with a low of $21.36 and high of $45.12.
In Dec 2026, ARS Pharmaceuticals Inc is projected to average $48.27, with a low of $33.53 and high of $57.15.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.